Joenja (leniolisib) - Pharming Group
https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/paper/ispor-europe-2025/poster-session-1-2/apds-treatment-in-germany-decision-criteria-costs-and-contribution-of-leniolisib-to-outcomes
 
Ulrich Baumann, MD 1; Marie-Celine Deau, PhD 2; Karsten Franke, MD 3; Leif G. Hanitsch, MD 4; Georgios Sogkas, MD PhD 5; Kirsten H Herrmann, PhD 6; Ulrich Bosch dos Santos, PhD 6; Christof Minartz, PhD 7; Aljoscha S Neubauer, MD MBA 7; Fabian Hauck, MD PhD 8.
 
Nov 11, 2025
 
Next